Fisher & Paykel Healthcare Corporation Limited

ASX:FPH ISIN:NZFAPE0001S2

The company designs, manufactures and markets heated humidification products and systems for use in respiratory care and the treatment of obstructive apnea. Its products and systems are sold in over 90 countries worldwide. 
 
     

查看其它語言版本

新聞

11月19日澳洲股市:市場在尋找新的方向

🕔11/19/2009 1:00:20 PM 16849

在一份令人失望的報告顯示美國10月份的住房開工數下降了10.6%、批准數下降了4.0%之後,昨晚華爾街結束了連日的上漲,收市下跌。這次下挫顯示房地產行業仍承受著壓力。

閱讀全文
###

72,291 公司背景瀏覽

  • 本頁瀏覽人次: (過去7日: 12) (過去30日: 109) (自發布以來: 10393) 

公司詳細

    傳真
  • +64 9 574 0158 
  • 主要部門
  • 醫療-製藥 
  • 支柱產業
  • 保健 
  • 主頁
  • www.fphcare.co.nz

更多新聞紀錄

  • 2025/04/10: FPH to announce full year results on 28 May 2025*
  • 2025/04/09: Change in substantial holding*
  • 2025/04/07: Ongoing Disclosure Notices - Employee Share Purchase Scheme*
  • 2025/04/07: Application for quotation of securities - FPH*
  • 2025/04/07: Application for quotation of securities - FPH*
  • 2025/04/03: New US tariffs announced today*
  • 2025/04/03: Application for quotation of securities - FPH*
  • 2025/03/12: FPH launches F&P Nova Nasal mask in NZ and AU*
  • 2025/03/11: Ongoing Disclosure Notices - Employee Share Purchase Plan*
  • 2025/03/06: FPH enters into construction contract for fifth NZ building*
*refer to company website